NiveshIQNiveshIQ
NSE: SANOFICONR  ·  Fast Moving Consumer Goods

Sanofi Consumer Healthcare India Ltd.

₹4,724.10▲ ₹4.10 (+0.09%)
Volume: 3,938Day Range: ₹4,637.30 – ₹4,799.9052W Range: ₹3,975.00 – ₹5,894.50
Price Chart  ·  Daily closes
1Y 6M 3M 1M 1W 1D
⚡ Intelligence Signals 5 active
🟢 Bullish Earnings Catalyst 📊 RS Laggard (5D) 🔄 Sector Sweep ⚡ Signals Aligned 📉 Pullback

NiveshIQ has detected 5 active signals on SANOFICONR. Sign up free to see what each signal means and how it affects the stock.

Unlock signals — free
Expected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74 / 100

About Sanofi Consumer Healthcare India Ltd.

Sanofi Consumer Healthcare India Limited, incorporated in 2023 and headquartered in Mumbai, operates as a fast‑moving consumer healthcare (FMCG) company under the umbrella of Opella Healthcare Participations B.V. The firm focuses on allergy, physical wellness, and pain care segments, with flagship brands such as Allegra, Combiflam, Avil, DePURA, and Festal. Distribution is multi‑channel, spanning wholesalers, government institutions, hospitals, pharmacy chains, and e‑commerce platforms, enabling broad market penetration across India. In the latest fiscal year, the company generated ₹950 crore in revenue and ₹266 crore in net income, reflecting a healthy profitability margin of approximately 28%. Recent developments include a strategic partnership with a leading e‑commerce platform to boost

Financial Highlights

MetricFY24FY25FY26
Revenue₹724.50 Cr₹724.50 Cr -6.70%₹878.40 Cr +21.24%
EBITDA Margin40.64%37.35%35.18%
Net Profit₹181.00 Cr₹181.00 Cr -7.20%₹240.10 Cr +32.65%
EPS–₹78.59₹104.27

Annual figures in Indian Rupees (Crores). Source: company filings (NSE).

Analyst ConsensusConsensus target ₹5,855.00  |  Buy 1 · Hold 0 · Sell 0Sign in to see →

Strategic Outlook

Patient volumes, occupancy, ARPOB/ARPO, case mix, and bed-capacity ramp-up remain the key forward drivers for the next 2...

FY26 (last completed FY): revenue ₹878 Cr, PAT ₹240 Cr, EBITDA margin 35.2%, EPS ₹104.27. Year-on-year: revenue YoY +21....

🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instant

More Fast Moving Consumer Goods stocks

All stocks on NiveshIQ →

Everything you unlock with a free account

⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SANOFICONR
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SANOFICONR alongside your other holdings
Unlock full SANOFICONR research — free
No credit card  ·  No trial  ·  Always free to start

Frequently Asked Questions

What AI signals does NiveshIQ provide for Sanofi Consumer Healthcare India Ltd.?

NiveshIQ detects active intelligence signals for Sanofi Consumer Healthcare India Ltd. (SANOFICONR) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.

What are the key financials for Sanofi Consumer Healthcare India Ltd.?

Sanofi Consumer Healthcare India Ltd. operates in the Fast Moving Consumer Goods sector. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.

Does NiveshIQ provide investment advice?

No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.

Viewing preview of Sanofi Consumer Healthcare India Ltd. — 5 active signals detected Unlock full analysis — free